propafenone has been researched along with Myocardial Infarction in 34 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of propafenone in preventing induction of ventricular tachycardia was evaluated in 25 consecutive patients (mean age 62 +/- 8 years) with remote myocardial infarction who underwent programmed electrical stimulation for ventricular arrhythmia using up to three extra-stimuli after basic drive at the right ventricular apex." | 9.06 | Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time. ( Dubuc, M; Kus, T; Lambert, C; Shenasa, M, 1990) |
| "A double-blind, placebo-controlled trial comparing the antiarrhythmic effects of lidocaine (given intravenously as a bolus injection of 100 mg followed by an infusion of 2 mg min-1) and propafenone (given as a bolus of 105 mg followed by 300 mg orally every 8 h) was conducted in the first 24 h following acute myocardial infarction." | 9.06 | A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction. ( Atallah, G; Ferry, S; Kirkorian, G; Marchand, A; Mathieu, MP; Moleur, P; Stahl, C; Touboul, P; Vrancea, F; Zoheir, F, 1988) |
| "A placebo-controlled single-blind study was performed to evaluate the efficacy of oral propafenone on stable potentially malignant ventricular tachyarrhythmias in 13 patients who had suffered a myocardial infarction two months or longer before the trial." | 9.06 | [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction]. ( Carratino, L; De Caro, E; Ferroni, A; Vecchio, C; Zoni Berisso, M, 1987) |
| "In 12 patients with coronary artery disease, 11 of them with previous myocardial infarction, the antiarrhythmic effects of orally administered flecainide (F." | 9.05 | [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. ( Fabry, E; Klempt, HW; Nayebagha, A, 1982) |
| "Propafenone, a new class I antiarrhythmic drug, given as a bolus injection followed by oral medication, or lidocaine were given to 20 consecutive patients admitted with chest pain suggesting acute myocardial infarction and showing high grades, i." | 9.05 | Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction. ( Ericsson, CG; Eriksson, S; Olsson, G; Rehnqvist, N; Svensson, G, 1984) |
| " The case history is reported of a patient with atrial flutter and atrial fibrillation who developed Brugada-like ECG changes when treated with propafenone." | 7.74 | Propafenone-induced Brugada-like ECG changes mistaken as acute myocardial infarction. ( Chutani, S; Grubb, B; Imran, N; Kanjwal, Y, 2008) |
| "In order to evaluate the effects of propafenone (an antiarrhythmic class 1 c agent) acutely administered intravenously on left ventricular function, 10 patients with acute myocardial infarction (AMI), affected by arrhythmias (greater than or equal to Lown class III), belonging to Killip class I and II, and with normal serum electrolyte levels, were studied 2-4 days after an acute episode." | 7.68 | [Effects of acute intravenous administration of propafenone on left ventricular function in patients with acute myocardial infarction]. ( Belli, C; Meloni, S; Nassiacos, D; Recalcati, F; Sali, M; Scarpini, S, 1990) |
| "The electrophysiological effects of lidocaine (L) and propafenone (P) in chronic myocardial infarction in relation to tissue drug concentrations (TDC) are unknown." | 7.67 | Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations. ( Agarwal, JB; Bracchetti, D; Helfant, RH; Naccarella, FF; Weintraub, WS, 1984) |
| "We describe a case of acute myocardial infarction complicated by atrial and ventricular arrhythmias in which it was possible to verify the effectiveness of lidocaine, mexiletine and propafenone." | 7.67 | Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. ( Aguglia, F; De Marzio, P; Gnecchi, M, 1985) |
| "The efficacy of intravenous cibenzoline (3 mg/kg), propafenone (4 mg/kg), and procainamide (20 mg/kg) against inducible sustained and nonsustained ventricular tachycardias (VT) was evaluated in 12 conscious dogs with chronic isolated right ventricular (RV) infarction." | 7.67 | The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. ( Ino, T; Karagueuzian, HS; Mandel, WJ; Meesmann, M; Ohta, M; Peter, T; Sugi, K, 1986) |
| "The anti-arrhythmic drug mexiletine caused an oesophageal ulcer, confirmed by endoscopy and biopsy, in a 72-year-old woman." | 7.66 | [Esophageal ulcer caused by mexiletine]. ( Rudolph, R; Seckfort, H; Seggewiss, H, 1983) |
| "Ventricular fibrillation is a complication in patients hospitalized for acute myocardial infarction." | 5.29 | Sixty-six episodes of ventricular fibrillation within four hours: electrical stability restored by propafenone. ( Bellone, P; Spirito, P; Vecchio, C, 1994) |
| "The efficacy of propafenone in preventing induction of ventricular tachycardia was evaluated in 25 consecutive patients (mean age 62 +/- 8 years) with remote myocardial infarction who underwent programmed electrical stimulation for ventricular arrhythmia using up to three extra-stimuli after basic drive at the right ventricular apex." | 5.06 | Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time. ( Dubuc, M; Kus, T; Lambert, C; Shenasa, M, 1990) |
| "A double-blind, placebo-controlled trial comparing the antiarrhythmic effects of lidocaine (given intravenously as a bolus injection of 100 mg followed by an infusion of 2 mg min-1) and propafenone (given as a bolus of 105 mg followed by 300 mg orally every 8 h) was conducted in the first 24 h following acute myocardial infarction." | 5.06 | A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction. ( Atallah, G; Ferry, S; Kirkorian, G; Marchand, A; Mathieu, MP; Moleur, P; Stahl, C; Touboul, P; Vrancea, F; Zoheir, F, 1988) |
| "A placebo-controlled single-blind study was performed to evaluate the efficacy of oral propafenone on stable potentially malignant ventricular tachyarrhythmias in 13 patients who had suffered a myocardial infarction two months or longer before the trial." | 5.06 | [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction]. ( Carratino, L; De Caro, E; Ferroni, A; Vecchio, C; Zoni Berisso, M, 1987) |
| "In 12 patients with coronary artery disease, 11 of them with previous myocardial infarction, the antiarrhythmic effects of orally administered flecainide (F." | 5.05 | [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. ( Fabry, E; Klempt, HW; Nayebagha, A, 1982) |
| "Propafenone, a new class I antiarrhythmic drug, given as a bolus injection followed by oral medication, or lidocaine were given to 20 consecutive patients admitted with chest pain suggesting acute myocardial infarction and showing high grades, i." | 5.05 | Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction. ( Ericsson, CG; Eriksson, S; Olsson, G; Rehnqvist, N; Svensson, G, 1984) |
| " The case history is reported of a patient with atrial flutter and atrial fibrillation who developed Brugada-like ECG changes when treated with propafenone." | 3.74 | Propafenone-induced Brugada-like ECG changes mistaken as acute myocardial infarction. ( Chutani, S; Grubb, B; Imran, N; Kanjwal, Y, 2008) |
| "In order to evaluate the effects of propafenone (an antiarrhythmic class 1 c agent) acutely administered intravenously on left ventricular function, 10 patients with acute myocardial infarction (AMI), affected by arrhythmias (greater than or equal to Lown class III), belonging to Killip class I and II, and with normal serum electrolyte levels, were studied 2-4 days after an acute episode." | 3.68 | [Effects of acute intravenous administration of propafenone on left ventricular function in patients with acute myocardial infarction]. ( Belli, C; Meloni, S; Nassiacos, D; Recalcati, F; Sali, M; Scarpini, S, 1990) |
| "6 mg/min for 4-40 hrs), Propafenone (1-2 mg/Kg in 5 min + continuous infusion of 10-15 mcg/Kg/min for 24 hrs) and Mexiletine (250 mg in 15 min + 250 mg in 1 hr) have been evaluated in patients with acute myocardial infarction complicated by sinus tachycardia and hyperdynamic pattern, ventricular or supraventricular arrhythmias." | 3.67 | Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction. ( Ambrosini, F; Finzi, A; Lo Masto, M; Lotto, A; Massari, FM; Pagnoni, F; Valentini, R, 1984) |
| "The electrophysiological effects of lidocaine (L) and propafenone (P) in chronic myocardial infarction in relation to tissue drug concentrations (TDC) are unknown." | 3.67 | Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations. ( Agarwal, JB; Bracchetti, D; Helfant, RH; Naccarella, FF; Weintraub, WS, 1984) |
| "We describe a case of acute myocardial infarction complicated by atrial and ventricular arrhythmias in which it was possible to verify the effectiveness of lidocaine, mexiletine and propafenone." | 3.67 | Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report. ( Aguglia, F; De Marzio, P; Gnecchi, M, 1985) |
| "The efficacy of intravenous cibenzoline (3 mg/kg), propafenone (4 mg/kg), and procainamide (20 mg/kg) against inducible sustained and nonsustained ventricular tachycardias (VT) was evaluated in 12 conscious dogs with chronic isolated right ventricular (RV) infarction." | 3.67 | The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. ( Ino, T; Karagueuzian, HS; Mandel, WJ; Meesmann, M; Ohta, M; Peter, T; Sugi, K, 1986) |
| "The anti-arrhythmic drug mexiletine caused an oesophageal ulcer, confirmed by endoscopy and biopsy, in a 72-year-old woman." | 3.66 | [Esophageal ulcer caused by mexiletine]. ( Rudolph, R; Seckfort, H; Seggewiss, H, 1983) |
| "Amiodarone has been demonstrated to be more efficacious than propafenone or sotalol in the Canadian Trial of Atrial Fibrillation." | 2.42 | Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. ( Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL, 2003) |
| "Ventricular fibrillation is a complication in patients hospitalized for acute myocardial infarction." | 1.29 | Sixty-six episodes of ventricular fibrillation within four hours: electrical stability restored by propafenone. ( Bellone, P; Spirito, P; Vecchio, C, 1994) |
| "Propafenone 2 mg/kg was injected intravenously in 21 dogs." | 1.28 | [Correlation of signal-averaged electrocardiograms with the threatening ventricular arrhythmia during recovery period of experimental acute myocardial infarction]. ( Zha, Y, 1991) |
| "Diprafenone (D) is a new class I c antiarrhythmic agent, structurally similar to propafenone." | 1.27 | Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarction. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G; Thale, J, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (61.76) | 18.7374 |
| 1990's | 9 (26.47) | 18.2507 |
| 2000's | 4 (11.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naccarelli, GV | 1 |
| Wolbrette, DL | 1 |
| Khan, M | 1 |
| Bhatta, L | 1 |
| Hynes, J | 1 |
| Samii, S | 1 |
| Luck, J | 1 |
| Chutani, S | 1 |
| Imran, N | 1 |
| Grubb, B | 1 |
| Kanjwal, Y | 1 |
| Klempt, HW | 1 |
| Nayebagha, A | 1 |
| Fabry, E | 1 |
| Rudolph, R | 1 |
| Seggewiss, H | 1 |
| Seckfort, H | 1 |
| Rehnqvist, N | 1 |
| Ericsson, CG | 1 |
| Eriksson, S | 1 |
| Olsson, G | 1 |
| Svensson, G | 1 |
| Finzi, A | 2 |
| Ambrosini, F | 2 |
| Pagnoni, F | 2 |
| Massari, FM | 2 |
| Valentini, R | 2 |
| Lotto, A | 2 |
| Lo Masto, M | 1 |
| Naccarella, FF | 1 |
| Agarwal, JB | 2 |
| Weintraub, WS | 2 |
| Bracchetti, D | 2 |
| Helfant, RH | 2 |
| von Philipsborn, G | 1 |
| Gries, J | 1 |
| Hofmann, HP | 1 |
| Kreiskott, H | 1 |
| Kretzschmar, R | 1 |
| Müller, CD | 1 |
| Raschack, M | 1 |
| Teschendorf, HJ | 1 |
| Mayrhofer, EF | 1 |
| Davogg, S | 1 |
| Feilhauer, GD | 1 |
| Pilecky, I | 1 |
| Seisenbacher, H | 1 |
| Vockner, H | 1 |
| Karagueuzian, HS | 2 |
| Fujimoto, T | 1 |
| Katoh, T | 1 |
| Peter, T | 2 |
| McCullen, A | 1 |
| Mandel, WJ | 2 |
| Câmpeanu, A | 1 |
| Rădoi, M | 1 |
| Serban-Pârâu, G | 1 |
| Pleşca, O | 1 |
| Nuţă, M | 1 |
| Teodorescu, V | 1 |
| Titirigă, M | 1 |
| Bellone, P | 1 |
| Spirito, P | 1 |
| Vecchio, C | 2 |
| Dobrotvorskaia, TE | 1 |
| Koroleva, ON | 1 |
| Gordina, OV | 1 |
| Marakanova, AV | 1 |
| Puljevic, D | 1 |
| Smalcelj, A | 1 |
| Durakovic, Z | 1 |
| Goldner, V | 1 |
| Bauer, A | 1 |
| Schnabel, PA | 1 |
| Schreiner, KD | 1 |
| Becker, R | 1 |
| Voss, F | 1 |
| Kraft, P | 1 |
| Senges, J | 1 |
| Licka, M | 1 |
| Kübler, W | 1 |
| Schoels, W | 1 |
| Akdemir, I | 1 |
| Davutoglu, V | 1 |
| Aksoy, M | 1 |
| de Brito, FS | 1 |
| Pereira, MH | 1 |
| Castro, I | 1 |
| Maia, IG | 1 |
| Winslow, E | 2 |
| Mason, R | 1 |
| Campbell, JK | 1 |
| Marshall, RJ | 1 |
| Zha, Y | 1 |
| Scarpini, S | 1 |
| Nassiacos, D | 1 |
| Meloni, S | 1 |
| Recalcati, F | 1 |
| Sali, M | 1 |
| Belli, C | 1 |
| Kus, T | 1 |
| Dubuc, M | 1 |
| Lambert, C | 1 |
| Shenasa, M | 1 |
| Aguglia, F | 1 |
| Gnecchi, M | 1 |
| De Marzio, P | 1 |
| Naccarella, F | 1 |
| Ambrosioni, E | 1 |
| Puddu, PE | 1 |
| Rouet, R | 1 |
| Touboul, P | 1 |
| Moleur, P | 1 |
| Mathieu, MP | 1 |
| Vrancea, F | 1 |
| Ferry, S | 1 |
| Kirkorian, G | 1 |
| Atallah, G | 1 |
| Marchand, A | 1 |
| Stahl, C | 1 |
| Zoheir, F | 1 |
| Zoni Berisso, M | 1 |
| Carratino, L | 1 |
| De Caro, E | 1 |
| Ferroni, A | 1 |
| Zacà, F | 1 |
| Rollo, P | 1 |
| Bombardini, T | 1 |
| Ghinelli, M | 1 |
| Mattace, R | 1 |
| Manetti, CF | 1 |
| Malavolta, E | 1 |
| Vaccarino, R | 1 |
| Puddu, P | 1 |
| Bianchi, G | 1 |
| Manfredonia, A | 1 |
| Lepori, G | 1 |
| Locatelli, A | 1 |
| Di Salvo, F | 1 |
| Thale, J | 1 |
| Gülker, H | 1 |
| Hindricks, G | 1 |
| Haverkamp, W | 1 |
| Bender, F | 1 |
| Sugi, K | 1 |
| Ohta, M | 1 |
| Meesmann, M | 1 |
| Ino, T | 1 |
| Arrigo, F | 1 |
| Bonanno, N | 1 |
| Baldari, S | 1 |
| Giannetto, M | 1 |
| Luzza, F | 1 |
| Kasanuki, H | 1 |
| Onishi, S | 1 |
| Hirosawa, K | 1 |
1 review available for propafenone and Myocardial Infarction
| Article | Year |
|---|---|
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Tria | 2003 |
8 trials available for propafenone and Myocardial Infarction
| Article | Year |
|---|---|
[Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Disease; Electrocardiogr | 1982 |
Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Heart | 1984 |
[Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
Topics: Angina Pectoris; Angina, Unstable; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Di | 1996 |
The influence of atenolol and propafenone on QT interval dispersion in patients 3 months after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Atenolol; Electrocardiography; Female; Follow-Up Studies; Humans; Male; | 1997 |
[Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system].
Topics: Administration, Oral; Adult; Aged; Cardiac Complexes, Premature; Clinical Trials as Topic; Female; H | 1979 |
Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time.
Topics: Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; Heart Conduction System; | 1990 |
A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Female; Heart Rupture, Post-Infar | 1988 |
[Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
Topics: Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Female; Follow-Up Studies | 1987 |
25 other studies available for propafenone and Myocardial Infarction
| Article | Year |
|---|---|
Propafenone-induced Brugada-like ECG changes mistaken as acute myocardial infarction.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Catheter Ablati | 2008 |
[Esophageal ulcer caused by mexiletine].
Topics: Aged; Cardiac Complexes, Premature; Esophageal Diseases; Female; Hemoptysis; Humans; Male; Mexiletin | 1983 |
[Hemodynamic effects of propafenone in acute myocardial infarct].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Hemodynamics; Humans; Male; Middle Aged; Myocard | 1984 |
Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Central Ve | 1984 |
Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbon Radioisotopes; Coronary Circulation; D | 1984 |
Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
Topics: Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Calcium Channel Blockers; Dogs | 1984 |
[Profound granulocytopenia in a patient treated with propafenon ].
Topics: Aged; Agranulocytosis; Anti-Arrhythmia Agents; Female; Humans; Myocardial Infarction; Propafenone; P | 1982 |
Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.
Topics: Animals; Arterial Occlusive Diseases; Coronary Disease; Depression, Chemical; Diastole; Dogs; Electr | 1982 |
[The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
Topics: Angina, Unstable; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Dr | 1993 |
Sixty-six episodes of ventricular fibrillation within four hours: electrical stability restored by propafenone.
Topics: Amiodarone; Electric Countershock; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; My | 1994 |
Effects of propafenone on anisotropic conduction properties within the three-dimensional structure of the canine ventricular wall.
Topics: Animals; Anisotropy; Anti-Arrhythmia Agents; Dogs; Heart; Heart Ventricles; Membrane Potentials; Myo | 2001 |
Intermittent Brugada syndrome misdiagnosed as acute myocardial infarction and unmasked with propafenone.
Topics: Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Diagnosis, Differential; Electrocardiography; Hu | 2002 |
Comparative hemodynamic effects of Org 7797, flecainide, and propafenone in anesthetized pigs with developing myocardial infarcts.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Dose-Response Relationship, Drug; Estrenes; Femal | 1992 |
Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.
Topics: Anesthetics; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Dogs; Electr | 1991 |
[Correlation of signal-averaged electrocardiograms with the threatening ventricular arrhythmia during recovery period of experimental acute myocardial infarction].
Topics: Animals; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Electrocardiography; Heart Ventricles; My | 1991 |
[Effects of acute intravenous administration of propafenone on left ventricular function in patients with acute myocardial infarction].
Topics: Aged; Blood Pressure; Drug Evaluation; Female; Heart; Heart Rate; Humans; Infusions, Intravenous; Ma | 1990 |
Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Dru | 1985 |
[Myocardial distribution of C-14 lidocaine and C-14 propafenone in relation to regional myocardial blood flow in a model of chronic-phase myocardial infarct].
Topics: Animals; Carbon Radioisotopes; Coronary Circulation; Dogs; Lidocaine; Microspheres; Myocardial Infar | 1988 |
Are different pharmacokinetic properties of lidocaine versus propafenone in normal as compared to ischemic myocardium responsible for different electrophysiologic effects which help preventing arrhythmias?
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Electrophysiology; Guinea Pigs; In Vitro Techni | 1988 |
[Evaluation using Tc-99m angioscintigraphy of the hemodynamic changes induced by orally administered propafenone in recent acute myocardial infarct].
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiac Volume; Female; Heart Rate; Hemodynamics; | 1988 |
[Arrhythmias in the rehabilitation period after myocardial revascularization surgery by aortocoronary bypass. Efficacy of anti-arrhythmia therapy with propafenone].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Myocar | 1986 |
Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarction.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Chemical Phenomena; Chemis | 1987 |
The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Drug Eval | 1986 |
[Effect of propafenone on left ventricular function in patients with myocardial infarct].
Topics: Aged; Anti-Arrhythmia Agents; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contra | 1985 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatogra | 1985 |